+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prophylactic use of liposomal amphotericin B against fungal infections A randomized trial in bone marrow transplant recipients



Prophylactic use of liposomal amphotericin B against fungal infections A randomized trial in bone marrow transplant recipients



Transplantation Proceedings 25(1 BOOK 1-2): 1495-1497




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032993184

Download citation: RISBibTeXText


Related references

Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients. Transplantation Proceedings 25(1 Pt 2): 1495-1497, 1993

Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant patients. Transplantation Proceedings 25(1 part 2): 1495-1497, 1993

Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplantation 12(6): 577-582, 1993

Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long term results of a randomized, placebo-controlled trial. Transplantation Proceedings 27(1): 1195-1198, 1995

Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation 59(1): 45-50, 1995

Antifungal prophylaxis in bone marrow transplant recipients Results of a double-blind randomized study of liposomal amphotericin B vs placebo. Journal of Cellular Biochemistry Supplement 0(18B): 62, 1994

Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients. Bone Marrow Transplantation 23(7): 697-703, 1999

A multicenter, retrospective study of amphotericin B -induced nephrotoxicity in pediatric bone marrow transplant recipients with invasive fungal infections. Pediatric Research 51(4 Part 2): 252A, 2002

Liposomal Amphotericin B Prevents Invasive Fungal Infections In Liver Transplant Recipients. Transplantation 59(1): 45-50, 1995

Treatment of fungal infections in heart transplant recipients using liposomal encapsulated amphotericin b. Journal of Heart Transplantation 7(1): 81, 1988

Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses. Pharmacoeconomics 2(6): 500-508, 1992

Liposomal amphotericin b ambisome treatment in bone marrow and organ transplant recipients. Bone Marrow Transplantation 5(SUPPL 2): 18, 1990

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients. Mycoses 39(5-6): 185-193, 1996

Liposomal amphotericin b ambisome treatment in bone marrow and solid organ transplant recipients. Journal of Cellular Biochemistry Supplement (14 PART A): 314, 1990

Invasive fungal infections in lung transplant recipients receiving prophylactic aerosolized amphotericin B formulations. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 401, 2002